Labeling revisions take aim against medication errors

The U.S. Pharmacopeia proposes revisions to ferrules and cap overseal labeling.

istock-pharmacopeia
istock-pharmacopeia

In an effort to help prevent medication errors, reports PharmTech.com, the U.S. Pharmacopeia posted a proposed revised standard “for what should and should not appear on the ferrules and cap overseals of medication drugs.”

USP’s Web site says, “The proposals will appear as an ‘In-Process Revision’ proposal in Pharmacopeial Forum 36(1) (January – February 2010) for a 90-day public comment period. Comments on the proposed revision will be accepted through April 15, 2010, and should be directed to [email protected].”

According to the U.S. FDA’s Web site, “medication errors cause at least one death every day and injure approximately 1.3 million people annually in the United States.” The site says errors can occur anywhere within the distribution chain, including repackaging, dispensing, and labeling. The agency offers several resources to help report and address medication errors.

Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—<i>Packaging World</i> editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
Annual Outlook Report: Sustainability
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO